Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 13 (NPM1P13) is a human genomic locus classified as a pseudogene, showing high sequence similarity to the functional Nucleophosmin 1 (NPM1) gene but not producing a functional protein[5]. There is no evidence of its transcription or translation, nor of any function in health or disease. Its primary significance lies in its potential to be misattributed as the real NPM1 gene, which is an important biomarker and therapeutic target in several cancers, especially acute myeloid leukemia.
None. No mechanisms of action are described for pseudogenes like NPM1P13.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 13 (NPM1P13).